Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01992120 · ClinicalTrials.gov registry record · NA

Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome

A NA study, sponsored by NYU Langone Health.

Terminated
Registry status
NA
Development phase
40
Enrollment target

NCT01992120 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01992120, a NA study, was terminated before completion, sponsored by NYU Langone Health.

TERMINATED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The primary objective of the proposed study will be to determine if a multi-modality teaching curriculum utilizing high-fidelity simulation and didactic lecture will result in sustained improvement by internal medicine residents in written knowledge and clinical performance when compared to residents receiving a curriculum utilizing only didactic lecture. The investigators hypothesis is that the addition of high-fidelity simulation to a traditional didactic lecture curriculum will result in sustained and superior written knowledge and practical performance when compared to a group receiving only didactic lecture on the same topic. Specifically, the investigators will be assessing internal medicine resident knowledge and performance in the area of sepsis in the hospitalized patient, and will shape the investigators teaching curriculum around this focus.

Interventions

  • OTHER Debriefing of high-fidelity sepsis simulation scenarios
  • OTHER Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2013-11
Est. Completion 2014-07
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT01992120

The ClinicalTrials.gov registry entry for NCT01992120 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Debriefing of high-fidelity sepsis simulation scenarios is the first listed.

NCT01992120 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01992120 about?

NCT01992120 is a clinical study titled "Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome". The primary objective of the proposed study will be to determine if a multi-modality teaching curriculum utilizing high-fidelity simulation and didactic lecture will result in sustained improvement by internal medicine residents in written knowledge and clinical performance when compared to resident...

What is the current status of trial NCT01992120?

This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2013-11. Estimated completion is 2014-07.

What interventions are being tested in trial NCT01992120?

The interventions under investigation include: Debriefing of high-fidelity sepsis simulation scenarios (OTHER), Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios (OTHER).

Who is sponsoring clinical trial NCT01992120?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.